Karuna Therapeutics Inc (DELISTED) (KRTX:DL)
329.83
0.00 (0.00%)
USD |
NASDAQ |
Mar 18, 16:00
Karuna Therapeutics Cash from Investing (Quarterly): 92.44M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 92.44M |
| September 30, 2023 | 28.31M |
| June 30, 2023 | -253.58M |
| March 31, 2023 | -27.49M |
| December 31, 2022 | -306.62M |
| September 30, 2022 | -292.02M |
| June 30, 2022 | -5.555M |
| March 31, 2022 | 17.80M |
| December 31, 2021 | -42.02M |
| September 30, 2021 | -50.37M |
| June 30, 2021 | 18.60M |
| March 31, 2021 | 51.10M |
| Date | Value |
|---|---|
| December 31, 2020 | 29.66M |
| September 30, 2020 | -66.83M |
| June 30, 2020 | -42.06M |
| March 31, 2020 | -10.43M |
| December 31, 2019 | -72.62M |
| September 30, 2019 | -42.18M |
| June 30, 2019 | -64.52M |
| March 31, 2019 | 4.983M |
| December 31, 2018 | -5.115M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-306.62M
Minimum
Dec 2022
92.44M
Maximum
Dec 2023
-54.65M
Average
-42.02M
Median
Dec 2021
Cash from Investing (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | -19.62B |
| RayzeBio inc (DELISTED) | -146.77M |
| Icosavax Inc (DELISTED) | -72.65M |
| Madrigal Pharmaceuticals Inc | -362.12M |
| Theseus Pharmaceuticals Inc (DELISTED) | 10.08M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -111.06M |
| Cash from Financing (Quarterly) | 19.87M |
| Free Cash Flow | -388.74M |
| Free Cash Flow Per Share (Quarterly) | -2.96 |
| Free Cash Flow Yield | -3.19% |